TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

Vor Bio Announces Pricing of Public Offering of $100 Million of Common Stock

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Vor Biopharma Inc.
Vor Bio Announces Pricing of Public Offering of $100 Million of Common Stock

Vor Biopharma is conducting a public offering of 10 million shares at $10 per share, expecting to raise $100 million. The offering includes an option for underwriters to purchase an additional 1.5 million shares.

Insights
VOR   neutral

The company is raising capital through a standard public offering, which is a common financial strategy for clinical-stage biotechnology companies to fund research and development